Evaluation of longitudinal passive immunity transfer against lumpy skin disease virus in calves by different serological methods
Veterinary Research Communications · 2024
DOI: 10.1007/s11259-024-10421-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Research Communications, 2024. Verfasst von Milena Samojlović und 6 weiteren Autor:innen. Beteiligte Einrichtung: Scientific Veterinary Institute "Novi Sad", Novi Sad, Serbia. milena.s@niv.ns.ac.rs. Hauptthemen laut MEDLINE: Lumpy Skin Disease, Lumpy skin disease virus, Immunity, Maternally-Acquired, Antibodies, Viral. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science, Technological Development and Innovation of the Republic of Serbia.
Abstract (Originalsprache)
To implement effective lumpy skin disease (LSD) control measures, such as timely vaccination, particularly in calves and serological monitoring, it is necessary to evaluate immune response after vaccination, both in adult cattle and in their calves. The aim of this study was to evaluate passive immunity transfer and duration of maternal antibodies against lumpy skin disease virus (LSDV) in calves born to vaccinated cows by two different serological methods. The longitudinal study was carried out on two farms in Serbia where no cases were reported during LSD outbreak in 2016. Fifteen cows on each farm were vaccinated and revaccinated with attenuated vaccine - Neethling strain. A total of 30 cows and 30 calves on both farms were included in the study. Serum samples from cows were collected on calving day and serum samples from their respective calves on days 10, 20, 30, 45, 60, 75, 90, 105 and 120 after birth. Colostrum samples were collected only from 15 cows on one farm. In order to determine the presence of antibodies against LSDV a total of 30 cow sera samples, 15 colostrum samples and 270 calf sera samples were examined by commercial enzyme-linked immunosorbent assay (ELISA) and modified virus neutralization test (VNT). Overall, the performance of both serological tests was very satisfactory. The results of this longitudinal study showed that persistence of passive immunity in calves is less than 4 months, and that most calves are not protected against LSDV at that age. Since the vaccination is the most important control measure against LSDV, the recommended age of six months for vaccination of calves born to vaccinated cows should be reassessed to achieve the most optimal protection against LSD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Scientific Veterinary Institute "Novi Sad", Novi Sad, Serbia. milena.s@niv.ns.ac.rs.
- Scientific Veterinary Institute "Novi Sad", Novi Sad, Serbia.
- Vetpro doo, Laboratory for Veterinary Clinical Diagnostics, Belgrade, Serbia.
- Department of Veterinary Medicine, Faculty of Agriculture, University of Novi Sad, Novi Sad, Serbia.
Förderung
- Ministry of Science, Technological Development and Innovation of the Republic of Serbia
Zitieren
APA
Samojlović, M., Petrović, T., Polaček, V., Lupulović, D., Lazić, G., Rogan, D., & Lazić, S. (2024). Evaluation of longitudinal passive immunity transfer against lumpy skin disease virus in calves by different serological methods. Veterinary Research Communications. https://doi.org/10.1007/s11259-024-10421-0
Vancouver
Samojlović M, Petrović T, Polaček V, Lupulović D, Lazić G, Rogan D, et al. Evaluation of longitudinal passive immunity transfer against lumpy skin disease virus in calves by different serological methods. Veterinary Research Communications. 2024. doi:10.1007/s11259-024-10421-0
BibTeX
@article{Samojlovi2024,
author = {Samojlović, Milena and Petrović, Tamaš and Polaček, Vladimir and Lupulović, Diana and Lazić, Gospava and Rogan, Dragan and Lazić, Sava},
title = {Evaluation of longitudinal passive immunity transfer against lumpy skin disease virus in calves by different serological methods},
journal = {Veterinary Research Communications},
year = {2024},
doi = {10.1007/s11259-024-10421-0}
}
EUVIMED